Population pharmacokinetics and thrombocytopenia risk assessment of linezolid in liver transplant recipients利奈唑胺在肝移植受者中的群体药代动力学和血小板减少症风险评估JOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62025-05-130PRE
Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients: initial therapy prior to pathogen differential diagnosis in ChinaFRONTIERS IN PUBLIC HEALTHIF3.42023-12-194OAAI
A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scaleBMC INFECTIOUS DISEASESIF32022-04-1111OAAI
Vancomycin-induced acute kidney injury after liver transplantationHEPATOBILIARY & PANCREATIC DISEASES INTERNATIONALIF4.42021-08-012PREAI
3,5-Dimethylorsellinic Acid Derived Meroterpenoids from Penicillium chrysogenum MT-12, an Endophytic Fungus Isolated from Huperzia serrataJOURNAL OF NATURAL PRODUCTSIF3.62017-09-2958PREAI
Analysis on embodied energy of China's export trade and the energy consumption changes of key industriesINTERNATIONAL JOURNAL OF ENERGY RESEARCHIF4.22013-09-178OAAI
First Demonstration of Cerebrospinal Fluid and Plasma Aβ Lowering with Oral Administration of a β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman PrimatesJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82009-01-01107PREAI
In vivo β-Secretase 1 inhibition leads to brain Aβ lowering and increased α-secretase processing of amyloid precursor protein without effect on neuregulin-1JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82008-03-01112PREAI
Discovery of isonicotinamide derived β-secretase inhibitors:: In vivo reduction of β-amyloidJOURNAL OF MEDICINAL CHEMISTRYIF6.82007-06-2159PREAI
LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's diseasePROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12006-11-2188OAAI
Discovery of oxadiazoyl tertiary carbinamine inhibitors of β-secretase (BACE-1)JOURNAL OF MEDICINAL CHEMISTRYIF6.82006-11-1085PREAI
Aminoethylenes: A tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1JOURNAL OF MEDICINAL CHEMISTRYIF6.82006-01-1267PREAI
Compounds that bind APP and inhibit Aβ processing in vitro suggest a novel approach to Alzheimer disease therapeuticsJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92005-05-0140OAAI
Structure-based design of potent and selective cell-permeable inhibitors of human β-secretase (BACE-1)JOURNAL OF MEDICINAL CHEMISTRYIF6.82004-11-11312PREAI
Identification of a small molecule nonpeptide active site β-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteasesJOURNAL OF MEDICINAL CHEMISTRYIF6.82004-10-30131PREAI
Inhibition of APP processing by substrate-binding compounds: A novel approach to amyloid loweringNEUROBIOLOGY OF AGINGIF3.52004-07-010PREAI
Novel mutations introduced at the β-site of amyloid precursor protein enhance the production of amyloid peptide by BACE1 in vitro and in cellsNEUROBIOLOGY OF AGINGIF3.52004-07-010PREAI
A genetically engineered mouse model with an enhanced beta-secretase substrate exhibits increased amyloid generationNEUROBIOLOGY OF AGINGIF3.52004-07-011PREAI
Presenilin-1 and presenilin-2 exhibit distinct yet overlapping γ-secretase activitiesJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92003-06-01177OAAI
Aβpp secretases are co-expressed with Aβpp in the pancreatic isletsJOURNAL OF ALZHEIMERS DISEASEIF3.12001-08-0727PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项